More Eye Drops Recalled Due to Infection Danger
By Physician’s Briefing Staff HealthDay Reporter
THURSDAY, Nov. 2, 2023 -- Cardinal Health is voluntarily recalling certain LEADER brand eye drops because they may cause eye infections.
The U.S. Food and Drug Administration informed the Dublin, Ohio, company that agency investigators found unsanitary conditions in its manufacturing facility. Tests of critical drug production areas of the facility were positive for bacteria. The drops were supplied by Velocity Pharma.
Cardinal Health has received reports of three adverse events related to these products and have shared this information with its supplier, the recall notice said.
These eye drops are sold over the counter for temporary relief of burning and irritation due to dryness, to protect against further irritation, and to relieve redness. They were sent to wholesalers and retailers starting in December 2021.
While the company is notifying its direct accounts via mail and arranging for return of the products, wholesalers, distributors, and retailers should stop selling the eye drops.
Consumers should also stop using them. They may return any of the recalled products to the place they bought them.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
AI Shows Good Clinical Knowledge, Reasoning for Eye Issues
FRIDAY, April 26, 2024 -- Large language models (LLMs) are approaching expert-level knowledge and reasoning skills in ophthalmology, according to a study published online April 17...
Childhood Amblyopia Linked to Cardiometabolic Dysfunction in Adults
WEDNESDAY, March 20, 2024 -- Adults who had childhood amblyopia have greater cardiometabolic dysfunction, according to a study published online March 7 in...
AI Outperforms Glaucoma, Retina Specialists for Diagnostic Accuracy
WEDNESDAY, Feb. 28, 2024 -- A large language model (LLM) chatbot outperforms glaucoma and retina specialists for diagnostic accuracy, according to a study published online Feb. 22...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.